Safety Practices in Community Pharmacy during COVID-19 Pandemic in Jordan
Keywords:Community pharmacy, COVID-19, pharmacies, infection, safety considerations, Jordan
Community pharmacies play a significant role in providing medicines, vaccines, consultations, and other important health services to the public. Community pharmacies continued to provide their services during the COVID-19 pandemic in most countries around the world, and this was the case in Jordan. During the COVID-19 pandemic, the pharmacy staff needs to avoid the risk of exposure to the virus causing COVID-19 along with reducing the risk for customers. This paper summarizes the safety practices of most community pharmacies in Jordan during the COVID-19 pandemic, to protect staff and customers from the risk of exposure to COVID-19 infection. Data were collected in two folds. First, a survey was distributed online through social media targeting those pharmacists working in community pharmacies. Second, face-to-face interviews were conducted with the staff and owners of pharmacies in Jordan, asking about the procedures followed to enhance the safety practices of pharmacists. Analyzing responses revealed that since the start of the pandemic, about 94% of pharmacists were using personal protective equipment, 88% of pharmacies were frequently sterilizing the pharmacy and the main door handle, and 82% of pharmacies were providing medical masks, gloves, and alcohol at the entrance.
Zhu N., Zhang D., Wang W., et al. A novel Coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020; 382: 727-733.
Hui D., Azhar E., Madani T., et al.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020; 94: 264-266.
Rajagopal k., Byran G., Swaminathan G. et al. Activity of Isoxazole substituted 9-aminoacridines against SARS CoV-2 main protease for COVID-19: A computational approach. Jordan J. pharm. sci. 2021; 14(4): 403-416.
Syahri J., Nurohmah B. and Yuanita E. Effectivity of Remdesivir and some compounds as therapeutic potential drugs for anti-SARS-CoV-2: in silico study. Jordan J. pharm. sci. 2021; 14(1): 49-62.
Benvenuto D., Giovanetti M., Ciccozzi A., et al.The 2019‐ new coronavirus epidemic: Evidencefor virus evolution. J. Med. Virol. 2020; 92(4): 455-459.
Lu R., Zhao X., Li J., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224): 565-574.
Kooraki S., Hosseiny M., Myers L. Coronavirus (COVID-19) Outbreak: What the department of radiology should know. J. Am. Coll. Radiol. 2020; 17(4): 447-451.
Centers for Disease Control and Prevention, considerations for pharmacies during the COVID-19 pandemic. Available from:
https://www.cdc.gov/coronavirus/2019-ncov/healthcare-resources/pharmacies.html . [Accessed 15 March 2020].
World Health Organization, rational use of personal protective equipment for coronavirus disease 2019 (COVID-19). Available from:
https://apps.who.int/iris/bitstream/handle/10665/331215/WHO-2019-nCov-IPCPPE_use-2020.1-eng.pdf. [Accessed 18 April 2020].
Rabionet S. Pharmacy education to transform and strengthen healthcare: A call for action and reflection during COVID-19 epidemic. Pharm. Health. Serv. Res. 2021; 12(2): 99–100.
Sridhar S. and Rabbani S. Pharmaceutical care services provided by pharmacists during COVID-19 pandemic: Perspectives from around the World. Pharm. Health. Serv. Res. 2021; 12: 463–468.
López-Hernández L., Díaz B., González E., et al. Quality and safety in healthcare for medical students: Challenges and the road ahead. Healthcare. 2020; 8(4): 540.